Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L. Karen Smith


  • Director at Antares Pharma Inc. (ATRS), 2020-06-16
  • Director at Sangamo Therapeutics Inc (SGMO), 2020-06-03
  • Evp, Chief Medical Officer at Emergent Biosolutions Inc. (EBS), 2020-05-28
  • Director at Acceleron Pharma Inc (XLRN), 2020-01-25
  • Evp, R&d And Cmo at Jazz Pharmaceuticals Plc (JAZZ), 2018-03-07
  • Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JAZZ $137.26 1 Officer 14,182 2016-08-12 Filing
JAZZ $137.10 607 Officer 14,181 2016-08-12 Filing
JAZZ $143.63 580 Officer 13,574 2016-07-13 Filing
JAZZ $149.61 557 Officer 12,994 2016-06-13 Filing